Around 9,000 people in Scotland are employed within the drug research and manufacturing industry, and the world-leading Dundee University Drug Discovery Unit could lose vital funding streams. Experts expressed concern in 2017 about the risk to international collaboration on medicines research
The loss of EU money will be a significant loss to the University of Brighton, says the pro vice chancellor for research and enterprise. Brighton University has received almost quarter of its research grants and contracts from the European Union since 2012, accruing more than £10 million.
Professor Julie Fitzpatrick, scientific director and chief executive of Scotland’s world class livestock disease centre, the Moredun Research Institute, has voiced her concerns over the yearly budget cuts being imposed by the Scottish Government. Of the total £13 million income generated by Moredun a year, 20% comes from EU funding.
Professor Gast said she remained “very concerned” about the uncertainty hanging over the Brexit negotiations as she disclosed that some of Imperial’s 2,000 EU staff had already left as a result, with about half of the remainder seeking legal advice.
Top of the “at risk” list are economics and modern languages, with 36% of economists and 35% of academics in modern language departments from EU countries. Next are mathematics (29%), physics (28%), classics and chemical engineering (26%) and politics and international relations (25%).
Menelas Pangalos, executive vice president of the Innovative Medicines and Early Development (IMED) Biotech Unit at AstraZeneca has said “We are being as supportive as we can but we are starting to see people turn us down in the UK because they are worried about the uncertainty”.